Vimarsana
Biggest News Aggregation in the World

Page 17 - Virtual Incision News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virtual Incision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virtual Incision Today - Breaking & Trending Today

The Surgical Robots Market is to grow by USD 7,892.61 million from 2022 to 2027|Growth driven by high adoption due to convenience - Vimarsana News

The Surgical Robots Market is to grow by USD 7,892.61 million from 2022 to 2027|Growth driven by high adoption due to convenience

/PRNewswire/ -- The surgical robot market is to grow by USD 7,892.61 million from 2022 to 2027. However, the growth momentum will progress at a CAGR of 20.67%...

Here's how much funding robotics companies raised in June - Vimarsana News

Here's how much funding robotics companies raised in June

The Robot Report tracked 51 funding rounds in June 2023, bringing the year-to-date funding total to more about $6.1 billion.

SHINE Technologies Appoints Experienced Company Builder to Board of Directors - Vimarsana News

SHINE Technologies Appoints Experienced Company Builder to Board of Directors

/PRNewswire/ -- SHINE Technologies, LLC, a next-generation fusion technology company, today announced the appointment of Dr. Frederick Robertson to the...

cultivate(MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA - Vimarsana News

cultivate(MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA

/PRNewswire/ -- cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies,...

Virtual Incision submits surgical robot for FDA de novo clearance - Vimarsana News

Virtual Incision submits surgical robot for FDA de novo clearance

Virtual Incision announced that it submitted its MIRA surgical robot to the FDA for de novo clearance review.